Results 171 to 180 of about 381,426 (191)
Some of the next articles are maybe not open access.

NKG2D ligands: key targets of the immune response

Trends in Immunology, 2008
NKG2D is an activating receptor expressed by NK and T cells. NKG2D ligands show a restricted expression in normal tissues, but they are frequently overexpressed in cancer and infected cells. The binding of NKG2D to its ligands activates NK and T cells and promotes cytotoxic lysis of the cells expressing these molecules.
Segundo, González   +4 more
openaire   +2 more sources

NKG2D ligands as therapeutic targets.

Cancer immunity, 2014
The Natural Killer Group 2D (NKG2D) receptor plays an important role in protecting the host from infections and cancer. By recognizing ligands induced on infected or tumor cells, NKG2D modulates lymphocyte activation and promotes immunity to eliminate ligand-expressing cells. Because these ligands are not widely expressed on healthy adult tissue, NKG2D
Paul, Spear   +3 more
openaire   +1 more source

Expression of NKG2D ligands is downregulated by β-catenin signalling and associates with HCC aggressiveness

Journal of Hepatology, 2021
Séverine Celton-Morizur   +2 more
exaly  

DOWNREGULATION OF NKG2D LIGANDS BY CMV

2007
The human cytomegalovirus (HCMV) is a ubiquitous pathogen causing morbidity risk in immune suppressed and immunodeficient patients.
openaire  

Viral inhibitors of NKG2D ligands

2009
Viral inhibitors of NKG2D ...
openaire  

People also looked at

Frontiers in Immunology, 2018
Alessandra Soriani   +2 more
exaly  

People also looked at

Frontiers in Immunology, 2015
Fahmin Basher, Jennifer D Wu
exaly  

Home - About - Disclaimer - Privacy